Empagliflozin

Dr. McPhee: This is not quite the best option in this case. Empagliflozin can an excellent drug, particularly for patients with certain co-morbidities, such as heart failure, chronic kidney disease, and established or high atherosclerotic cardiovascular (ASCVD) risk. It can also help when weight loss is a goal. There is no compelling cardiorenal indication to start it ahead of another drug that is more cost-effective and could also provide benefits in preventing complications and reducing weight.

Please go back and reconsider.

  • clinical examination [undo]
  • Surfactant-Consultant [undo]
  • Step 1 [undo]
  • Digoxin (digitalis, positive inotropic drug) [undo]
  • Treatment [undo]
  • Empagliflozin [undo]
  • Learn about cognitive decline and aging [undo]
  • De la 50nm până la 1mm [undo]
  • steroids – diuretics – split bili and other tests [undo]
  • Opțiunea 1 [undo]
  • Піти до лікаря / викликати швидку. [undo]
  • Η ποιότητα ζωής του ασθενούς χειροτερεύει [undo]
  • Ramipril (ACE inhibitor) [undo]
  • Basic Enzyme Definitions [undo]
  • I couldn’t see you clearly, can we adjust the visual presentation? [undo]
  • Start plasma exchange (PEx) and steroids [undo]
  • Пацієнт — Микола, 47 років, страждає від серцебиття. [undo]
  • Salmeterol (LABA) [undo]
  • Έναρξη [undo]
  • Adverse effect to paracetamol [undo]
  • Opțiunea 2 [undo]
  • Observation [undo]
  • Ορισμός 2 [undo]
  • Answer [undo]
  • Salbutamol (SABA) [undo]
  • Go to espresso house [undo]
  • Decreased levels of HDL [undo]
  • Empagliflozin [undo]

Map: Michael Green_GEMD_1 (1115)
Node: 21088
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway